Who needs access to a specialty pharmacy? More people all the time.
Specialty pharmacies fulfill the specialty medication needs for complex and chronic conditions, such as multiple sclerosis, cancer, rheumatoid arthritis, and others.
The specialty pharmacy market is projected to expand by 8% each year with a growing number of patients prescribed specialty medications, as a result of:
- FDA approvals of new specialty medications
- Expanded usage of already approved specialty medications
- An aging U.S. population facing additional health challenges
The amount of people in the U.S. who need a specialty medication is anticipated to increase significantly over the next decade. By 2030, an additional 14 million Americans are projected to have a chronic medical condition treated by specialty medications. In particular, cancer patients are predicted to experience even greater increases, such that the number of Americans prescribed a specialty medication will double or triple over the next five years.
How specialty pharmacies rise to this challenge of growing need makes a real difference. First, patients with better adherence correlate with improved health outcomes. Second, specialty medications represent a significant cost to both payers and patients – and this cost is better controlled when patients have better treatment adherence. BioPlus Specialty Pharmacy focuses on patient adherence, which helps with both treatment outcomes and better controlled medical expenditures.
As always, BioPlus Specialty Pharmacy is ready to partner with your office as the ‘fast & easy’ way to get your patients referred for the specialty medications they need.
Related Posts
Polypharmacy Calls for a Specialty Pharmacist
Ongoing health issues tend to come with the need for multiple medications. This is so common that...
Skip the Chemo?
Breast cancer treatments have made impressive strides in terms of increasing survival rates for...
HCV Testing and Treatment: The Time is Now
There are nearly 4 million Americans with chronic hepatitis C infections, yet only 9% of them have...
Cancer Treatment Slowdowns
Prior authorizations can present one of the biggest obstacles to patients diagnosed with cancer....